BioNTech to close three German sites
BioNTech announced plans to shut down three German manufacturing sites affecting up to 1,860 jobs after failing to secure buyers. The restructuring marks a shift away from pandemic era production as vaccine manufacturing moves to partner Pfizer.
Xurve View
Insights:
Xurve View